Cellectis (CLLS) Revenue (2015 - 2026)
Cellectis (CLLS) recorded Revenue of $5.23 million in Q2 2026, down 68.7% from $16.73 million a year earlier and down 9.5% from the prior quarter.
Powered by 
Analysis
Cellectis (CLLS) Revenue (2015 - 2026) Analysis & Trends
On a TTM basis, Cellectis' Revenue came in at $58.89 million as of Jun 30, 2026, up 4.6% year-over-year; for FY2025, it was $72.95 million, up 75.8% from FY2024.
- Annual Revenue has a five-year compound annual growth rate of 26.1% (FY2020 to FY2025).
- Across earlier years, Revenue came in at $41.51 million in FY2024, $755,000 in FY2023 (-96.1%), $19.17 million in FY2022 (-36.8%) and $30.35 million in FY2021 (+32.6%).
- The Q2 2026 figure is the lowest quarterly Revenue since Q1 2024.
- On a year-over-year basis, Revenue rose in three of the last six quarters, with growth averaging 40.9%.
- Peak year-over-year performance for Revenue in the last five years was growth of 135.3% in Q1 2025, against a decline of 98.2% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $5.78 million (Q1 2026), $12.72 million (Q4 2025) and $35.17 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Cellectis | 147.50 Mn | -605.90 Mn | - | 5.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.23 Mn |
| Mar 31, 2026 | 5.78 Mn |
| Dec 31, 2025 | 12.72 Mn |
| Sep 30, 2025 | 35.17 Mn |
| Jun 30, 2025 | 16.73 Mn |
| Mar 31, 2025 | 10.66 Mn |
| Dec 31, 2024 | 12.72 Mn |
| Sep 30, 2024 | 16.20 Mn |
| Jun 30, 2024 | 8.06 Mn |
| Mar 31, 2024 | 4.53 Mn |
| Dec 31, 2023 | 283,000.00 |
| Sep 30, 2023 | 155,000.00 |
| Jun 30, 2023 | 178,000.00 |
| Mar 31, 2023 | 139,000.00 |
| Dec 31, 2022 | 16.02 Mn |
| Sep 30, 2022 | 175,000.00 |
| Jun 30, 2022 | 1.31 Mn |
| Mar 31, 2022 | 1.67 Mn |
| Dec 31, 2021 | 10.26 Mn |
| Sep 30, 2021 | 8.31 Mn |
API Access
Cellectis Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=CLLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "CLLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=CLLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();